ANGO vs PSX · rev $292.5M vs P/E 17, rev $143.15B
AngioDynamics Inc (ANGO) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
ANGO currently screens at market cap $378.5M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the ANGO and PSX stock pages for the full models.
Not investment advice.